● Recruiting

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Condition: Desmoid Tumor · Aggressive Fibromatosis · Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

PhasePhase 4

Planned participants50

Who can joinFemale, 18 Years to 40 Years

Healthy volunteersNo

About this study

This study is being conducted to study how nirogacestat may affect the ovarian function of adult premenopausal women with progressing desmoid tumors/aggressive fibromatosis.

This description comes directly from the study's public registry record.

Talk to the study team

US Medical Information · 888-275-7376 · eMediUSA@emdserono.com

Always discuss trial participation with your own doctor first.

Locations (23)

Cliniques Universitaires Saint-Luc (CUSL)	Brussels, Belgium	Recruiting
Universitaetsmedizin Mannheim	Mannheim, Germany	Recruiting
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.	Meldola, Forli-Cesena, Italy	Recruiting
La Fondazione e l'Istituto di Candiolo	Candiolo, Torino, Italy	Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola	Bologna, Italy	Recruiting
IRCCS Istituto Ortopedico Rizzoli di Bologna	Bologna, Italy	Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori Milano	Milan, Italy	Recruiting
Istituto Nazionale Tumori I.R.C.C.S- Fondazione G. Pascale	Naples, Italy	Recruiting
Policlinico Universitario Campus Bio-Medico	Roma, Italy	Recruiting
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL)	Amsterdam, Netherlands	Recruiting
Academisch Ziekenhuis Leiden	Leiden, Netherlands	Recruiting
Hospital de la Santa Creu i Sant Pau	Barcelona, Spain	Recruiting

+ 11 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07176689